Emzumab

Emzumab Injection is used to treat moderate to severe asthma and chronic spontaneous urticaria (hives). In some cases, doctors may also prescribe Emzumab Injection to treat food allergies in patients who do not get enough relief from standard treatments.

No. Emzumab Injection is not a rescue medicine. It does not treat sudden asthma attacks, status asthmaticus, or emergency allergic reactions like anaphylaxis. You will still need a rescue inhaler or other crucial medicines for emergencies.

People should not receive Emzumab Injection if they are allergic to omalizumab or any ingredient in the medicine. Severe allergic reactions can occur, even after long-term use.

Yes. Emzumab Injection may cause serious allergic reactions (anaphylaxis), which can be life-threatening. It can happen right after the first dose or even more than a year after starting treatment. Signs include swelling of the throat or tongue, trouble breathing, dizziness, or fainting. Emergency medical care is needed in these cases.

Some studies have reported malignancies (cancers) in patients treated with Emzumab Injection, though the risk is not fully established. Your doctor will weigh the benefits against potential risks before starting treatment.